CVB homepage

Trending
Resistance training reduces heart attack risk in women
More than 11K bottles of blood pressure drug recalled
Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes
Cardiology still one of the top specialties for FDA-cleared AI algorithms
'Not sustainable': The real impact of RVU cuts in electrophysiology
The A-FLUX Reducer System from VahatiCor is designed to treat coronary microvascular dysfunction.
First US patient enrolled in device study to reduce coronary microvascular dysfunction

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Impella users need to monitor for blood leaks at the sidearm and hub of the introducer sheath shown below here introducers.
Blood may leak out of Impella introducers due to manufacturing defect

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Devi Nair, MD, director of electrophysiology and research at St. Bernards Medical Center and the Arrhythmia Research Group, explains new technology advances in leadless pacing for conduction pacing and Bachmann's bundle pacing.
Advances in leadless conduction and Bachmann’s bundle pacing next frontier in physiologic pacing

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

 

Product Recall
FDA announces new IABP recall after 4 serious injuries, 1 death

The new recall includes nearly 4,500 devices. There have been 134 incidents so far, including 5 adverse events.  

A team in China treated 10 patients—split evenly between men and women—with the SinoCrown TAVR valve developed by Lepu Medical Technology Company. The average patient age was 77.5 years old.
New self-expanding TAVR valve shows promise

It is still early for this new-look TAVR valve, but initial findings out of China include a procedural success rate of 100% and no deaths, disabling strokes or myocardial infarctions after 30 days. Read a full analysis from the team using the device. 

New data from the American Heart Association (AHA), published Jan. 25, 2023, in Circulation, suggests it resulted in a significant increase in the number of patients dying from cardiovascular disease (CVD) and a higher age-adjusted mortality rate. Oxygen Mask
COVID-19 caused CVD deaths in the U.S. to spike, new research confirms

Researchers explored updated data from the AHA, noting that the number of CVD-related deaths increased from more than 874,000 in 2019 to more than 928,000 in 2020.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.
Cardiologist Valentin Fuster honored with prestigious award

Fuster, one of the world’s most prominent cardiologists, said the award was a "great honor," especially since he was born in Barcelona. 

Thomas E. MacGillivray elected president of Society of Thoracic Surgeons. #STS
Thomas E. MacGillivray elected president of Society of Thoracic Surgeons

“There has never been a more exciting time to be a cardiothoracic surgeon,” the veteran surgeon said in a statement. 

Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients. A new analysis in European Heart Journal explored that exact issue, providing cardiology professionals with a step-by-step breakdown of how to get the most out of this potentially game-changing technology.
AI in cardiology: A step-by-step guide to developing high-quality algorithms

Overwhelmed or confused by AI and machine learning technology? A new analysis in European Heart Journal hopes to provide some clarity. 

Innovation at work

Cardiovascular Business
Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipients

Follow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms.  

In cooperation with CareDx

Around the web

Health Exec
Former high-level health officials think out loud about HHS, FDA
Radiology Business
Rad tech society establishes scholarships in memory of 2 influential members
Radiology Business
FDA clears RadNet's AI-powered breast arterial calcification solution